Mode
Text Size
Log in / Sign up

tezepelumab

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of tezepelumab

10 trials tracked of tezepelumab: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 138 citations.

10Trials tracked
4Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 4 Phase 2 2 Phase 1 4
  1. Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma Completed · 138 cited
  2. Phase 3 Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma Completed · 138 cited
  3. Phase 3 Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma Completed · 13 cited
  4. Phase 3 Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma Completed · 3 cited
  5. Phase 2 Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) Completed
  6. Phase 2 Tezepelumab COPD Exacerbation Study Completed
Show 4 more trials
  1. Phase 1 Safety Study of Tezepelumab (AMG 157) in Healthy Adults Completed
  2. Phase 1 Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis Completed
  3. Phase 1 Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma Completed
  4. Phase 1 Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.